Latest Articles

The new home of industrialised proteomics

The ACRF International Centre for the Proteome of Cancer (ProCan) will serve as the flagship for 'industrialised proteomics' — that is, large-scale protein...

Molecular biology 04 February, 2016

TBG Diagnostics relisted on ASX

TBG Diagnostics, formerly known as Progen Pharmaceuticals, has been relisted on the ASX under the code TDL.

Health & medical 03 February, 2016

Australian cancer drug licensed for $730m

A promising new cancer drug, developed by the Cancer Therapeutics CRC (CTx), has been licensed to pharmaceutical company MSD for $730 million.

Biotechnology 01 February, 2016

Proposed stem cell trial on track for approval

Cynata Therapeutics has received favourable advice from the UK Medicines and Healthcare products Regulatory Agency, causing shares in the regenerative medicine company to...

Biotechnology 29 January, 2016

The eyes have it — bionically

UNSW engineers have developed a bionic eye with the potential to aid the blind in the same way that the cochlear implant has aided the deaf.

Biotechnology 28 January, 2016

Biotechnology
Australian cancer drug licensed for $730m

Australian cancer drug licensed for $730m

A promising new cancer drug, developed by the Cancer Therapeutics CRC (CTx), has been licensed to pharmaceutical company MSD for $730 million.

Article 01 February, 2016
Health medical
Parkinson's progress halted in study patients

Parkinson's progress halted in study patients

Shares in Living Cell Technologies leapt over 40% after the biotechnology company revealed that it had halted the progression of Parkinson's...

Article 27 January, 2016
Life sciences
Hyperactive monocytes key to childhood food allergies?

Hyperactive monocytes key to childhood food allergies?

A new Australian study has found an immune 'signature' that identifies babies at risk of developing allergies to common foods in their...

Article 15 January, 2016
  • All content Copyright © 2016 Westwick-Farrow Pty Ltd